Potential Growth Opportunities in the Global House Dust Mite Allergy Sector with Comprehensive Details of Drug Candidates
Wednesday, November 18, 2020
DUBLIN, Nov. 10, 2020 /PRNewswire/ -- The "House Dust Mite Allergy R&D Pipeline Analysis Report, Q4 2020" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The Q4 House Dust Mite Allergy pipeline report is part of the immunology disease pipeline service. This quarterly review describes the pipeline of drugs under development for House Dust Mite Allergy, provides an update on the mechanism of action and targets, licensing and collaboration opportunities, company profiles including their business information, and market developments.
Scope and Coverage
-- House Dust Mite Allergy pipeline development activities across the early
phase, mid-stage, and late phase pipelines including therapeutic
candidates
-- Drug profiles comprising of drug overview, mechanism of action,
co-developers, originators, route of administration, molecule type,
orphan drug status, new molecular entity, area, and other details.
-- Company-company partnerships, company-institute partnerships, and
investment details of companies are included
-- 9 companies are included including Advagene Biopharma Co Ltd, ALK-Abello
AS, Allergy Therapeutics Plc, Anergis SA, Biomay AG, Genetic Immunity
Inc, Polyrizon Ltd, Roxall Medizin GmbH, Stallergenes Greer plc,
-- Disease overview, Pipeline trends, market analysis, and other
developments
-- Potential licensing/new business opportunities in House Dust Mite
Allergy pipeline market
Highlights
-- Global coverage of companies and pipeline agents
-- 2020 Trends, market analysis, and developments
-- Potential growth opportunities
-- Comprehensive details of drug candidates
Key report benefits:
-- Drive pipeline research and commercial assessment
-- Assess most promising drug candidates and stay ahead of the competition
-- Strengthen your pipeline through identifying business expansion and
acquisition opportunities
-- Develop new candidates based on most focused targets and mechanism of
actions
Key Topics Covered:
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. House Dust Mite Allergy Pipeline Trends and Insights
2.1 Dominant Phase type of House Dust Mite Allergy Pipeline, 2020
2.2 Most focused Mechanism of Action in House Dust Mite Allergy Pipeline
2.3 Leading type of Route of Administration during 2020
2.4 Proportion of New Molecular Entities in House Dust Mite Allergy pipeline
2.5 Active Companies Developing House Dust Mite Allergy pipeline
3. House Dust Mite Allergy Disease Types, Symptoms, Causes, and Available Treatment Options
3.1 Disease Overview
3.2 Types
3.3 Symptoms
3.4 Approved Treatment Options
4. House Dust Mite Allergy Pipeline Company Trends and Insights- Business Profiles, Drug Candidates and Contacts
-- Advagene Biopharma Co Ltd
-- ALK-Abello AS
-- Allergy Therapeutics Plc
-- Anergis SA
-- Biomay AG
-- Genetic Immunity Inc
-- Polyrizon Ltd
-- Roxall Medizin GmbH
-- Stallergenes Greer plc
5. House Dust Mite Allergy Pipeline Drug Profiles
5.1 Current Status of Drug and Vaccine Candidates
5.2 Drug Snapshot
5.2.1 Drug
5.2.2 Mechanism of Action
5.2.3 Phase
5.2.4 Co-Developer
5.2.5 Originator
5.2.6 Synonym
5.2.7 Route of Administration
5.2.8 Type of Molecule
5.2.9 Orphan Drug Status
5.2.10 New Molecular Entity
5.2.11 Area
5.3 Drug Details
5.4 Mechanism of Action
5.5 Licensing/Collaboration Agreements
5.6 Clinical Trial Details
6. House Dust Mite Allergy Pipeline Market News and Developments during 2020
7. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/gma27y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/potential-growth-opportunities-in-the-global-house-dust-mite-allergy-sector-with-comprehensive-details-of-drug-candidates-301169785.html
SOURCE Research and Markets
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
StackGen Named in Four Gartner® Hype Cycles(TM) for Platform Engineering, Infrastructure Strategy, Site Reliability Engineering, and I&O Automation in 2025 | Jan 22, 2026
|
|
|
